Prioritization of Eleven-Nineteen-Leukemia (ENL) inhibitors as orally available drug candidates for acute myeloid leukemia

被引:0
|
作者
Liu, Wenshe R.
Guo, Xuejiao
Alta, Sandeep
Xu, Shiqing
机构
关键词
D O I
10.1158/1538-8514.CANCERCHEM24-A013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A013
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
    Xiaoyan Liu
    Yuping Gong
    Biomarker Research, 7
  • [22] Role of angiogenesis inhibitors in acute myeloid leukemia
    Fiedler, W
    Staib, P
    Kuse, R
    Dührsen, U
    Flasshove, M
    Cavalli, F
    Hossfeld, DK
    Berdel, W
    CANCER JOURNAL, 2001, 7 : S129 - S133
  • [23] Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance
    Ran, Dan
    Schubert, Mario
    Taubert, Isabel
    Eckstein, Volker
    Bellos, Frauke
    Jauch, Anna
    Chen, Hui
    Bruckner, Thomas
    Saffrich, Rainer
    Wuchter, Patrick
    Ho, Anthony D.
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (02) : 155 - 165
  • [24] Spiroarborin, an ent-Clerodane Homodimer from Callicarpa arborea as an Inhibitor of the Eleven-Nineteen Leukemia (ENL) Protein by the YEATS Domain
    Pu, De-Bing
    Guo, Si-Qi
    Ni, Dong-Xuan
    Lin, Jing
    Gao, Jun-Bo
    Li, Xiao-Ning
    Zhang, Rui-Han
    Li, Xiao-Li
    Luo, Cheng
    Chen, Shi-Jie
    Xiao, Wei-Lie
    JOURNAL OF NATURAL PRODUCTS, 2022, 85 (02): : 317 - 326
  • [25] Applying ENL Risk Stratification Schema on a Local Acute Myeloid Leukemia Cohort in Kuwait
    Almazyad, Mazyad Jamal
    Pandita, Ramesh
    Ram, Mohan
    Alshemmari, Salem
    BLOOD, 2020, 136
  • [26] Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia
    Juan Eduardo Megías-Vericat
    Antonio Solana-Altabella
    Octavio Ballesta-López
    David Martínez-Cuadrón
    Pau Montesinos
    Annals of Hematology, 2020, 99 : 1989 - 2007
  • [27] Antibody–drug conjugates in acute myeloid leukemia
    David A Scheinberg
    Joseph G Jurcic
    Peter Maslak
    Nature Clinical Practice Oncology, 2006, 3 : 238 - 239
  • [28] Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia
    Eduardo Megias-Vericat, Juan
    Solana-Altabella, Antonio
    Ballesta-Lopez, Octavio
    Martinez-Cuadron, David
    Montesinos, Pau
    ANNALS OF HEMATOLOGY, 2020, 99 (09) : 1989 - 2007
  • [29] Recent drug approvals for acute myeloid leukemia
    Catherine Lai
    Kimberley Doucette
    Kelly Norsworthy
    Journal of Hematology & Oncology, 12
  • [30] Assessment of drug resistance in acute myeloid leukemia
    Funato, T
    Harigae, H
    Abe, S
    Sasaki, T
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2004, 4 (05) : 705 - 713